Literature DB >> 1310249

Explanation at the opioid receptor level for differing toxicity of morphine and morphine 6-glucuronide.

D Hucks1, P I Thompson, L McLoughlin, S P Joel, N Patel, A Grossman, L H Rees, M L Slevin.   

Abstract

The radiolabelled opioid receptor binding affinities of morphine and its active metabolite morphine 6-glucuronide at the total mu, mu 1, mu 2 and delta receptors were determined. Morphine 6-glucuronide was found to have a 4-fold lower affinity for the mu 2 receptor (IC50 17 nM and 82 nM for morphine and morphine 6-glucuronide respectively, P = 0.01), the receptor postulated to be responsible for mediating the respiratory depression and gastrointestinal effects after morphine. This provides a possible explanation for the reduced respiratory depression and vomiting seen following morphine 6-glucuronide in man. A similar reduction in affinity of morphine 6-glucuronide was seen at the total mu receptor whilst there was no significant difference seen at the mu 1 or delta receptor. Hence the increased analgesic potency of morphine 6-glucuronide over morphine remains unexplained.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310249      PMCID: PMC1977344          DOI: 10.1038/bjc.1992.23

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

1.  The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog.

Authors:  P E Gilbert; W R Martin
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

2.  Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.

Authors:  M J Millan; A Członkowski; A Lipkowski; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1989-10       Impact factor: 4.030

3.  Medical student numbers and medical manpower.

Authors: 
Journal:  Lancet       Date:  1987-03-28       Impact factor: 79.321

4.  A comparative study in rats of the respiratory depression and analgesia induced by mu- and delta-opioid agonists.

Authors:  A Pazos; J Flórez
Journal:  Eur J Pharmacol       Date:  1984-03-16       Impact factor: 4.432

5.  C57BL/6J-bgJ (beige) mice: differential sensitivity in the tail flick test to centrally administered mu- and delta-opioid receptor agonists.

Authors:  J R Mathiasen; R B Raffa; J L Vaught
Journal:  Life Sci       Date:  1987-05-18       Impact factor: 5.037

6.  Enhanced binding of morphine and nalorphine to opioid delta receptor by glucuronate and sulfate conjugations at the 6-position.

Authors:  K Oguri; I Yamada-Mori; J Shigezane; T Hirano; H Yoshimura
Journal:  Life Sci       Date:  1987-09-21       Impact factor: 5.037

7.  Different effects of mu and delta opiate agonists on respiration.

Authors:  M P Morin-Surun; E Boudinot; G Gacel; J Champagnat; B P Roques; M Denavit-Saubie
Journal:  Eur J Pharmacol       Date:  1984-02-17       Impact factor: 4.432

8.  Endogenous opioid peptides: multiple agonists and receptors.

Authors:  J A Lord; A A Waterfield; J Hughes; H W Kosterlitz
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

9.  Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain.

Authors:  A Goldstein; L I Lowney; B K Pal
Journal:  Proc Natl Acad Sci U S A       Date:  1971-08       Impact factor: 11.205

10.  Interaction of naloxone with mu- and delta-opioid agonists on the respiration of rats.

Authors:  A Pazos; J Flórez
Journal:  Eur J Pharmacol       Date:  1983-02-18       Impact factor: 4.432

View more
  12 in total

1.  Morphine-6 beta-glucuronide has a higher efficacy than morphine as a mu-opioid receptor agonist in the rat locus coeruleus.

Authors:  P B Osborne; B Chieng; M J Christie
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

Review 3.  Role of active metabolites in the use of opioids.

Authors:  Janet K Coller; Lona L Christrup; Andrew A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  2008-10-29       Impact factor: 2.953

Review 4.  Opioid metabolism.

Authors:  Howard S Smith
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

Review 5.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

6.  Effects of morphine metabolites on micturition in normal, unanaesthetized rats.

Authors:  Y Igawa; D Westerling; A Mattiasson; K E Andersson
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  Paradoxical pain.

Authors:  C L Davis; R Turner
Journal:  BMJ       Date:  1993-03-20

8.  Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children.

Authors:  R D Hain; A Hardcastle; C R Pinkerton; G W Aherne
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

9.  Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium.

Authors:  J Huwyler; J Drewe; C Klusemann; G Fricker
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

Review 10.  Morphine-6-glucuronide: an analgesic of the future?

Authors:  J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.